Profil
Jacob Falck Hansen joined Novo Nordisk in 2007.
He holds an MSc in biochemistry and a PhD from the University of Copenhagen.
He has broad scientific background including extensive experience within cancer biology and is the author or co-author of 23 peer-reviewed scientific publications.
In 2005 he received the Danish Research Council Young Researcher’s Award.
Prior to joining Novo Nordisk, Jacob Falck Hansen was a Senior Scientist at the Danish Cancer Society
Anciens postes connus de Jacob Falck Hansen
| Sociétés | Poste | Fin |
|---|---|---|
Novo Nordisk (Private Equity)
 Novo Nordisk (Private Equity) Investment ManagersFinance Novo Nordisk A/S (CO: NOVO.B; NYSE: NVO), a Danish healthcare company which manufactures and markets pharmaceutical products and services worldwide, invests through their corporate venture fund NNBF-Novo Nordisk Biotech Fund (NNBF). Based in Bagsværd near Copenhagen, NNBF is a business unit within Novo Nordisk A/S, responsible for the company's venture capital activities. Investments are made on the books of Novo Nordisk A/S out of internal financial resources. NNBF is managed as an evergreen fund. | Private Equity Investor | 01/02/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Novo Nordisk (Private Equity)
Novo Nordisk (Private Equity) Investment ManagersFinance Novo Nordisk A/S (CO: NOVO.B; NYSE: NVO), a Danish healthcare company which manufactures and markets pharmaceutical products and services worldwide, invests through their corporate venture fund NNBF-Novo Nordisk Biotech Fund (NNBF). Based in Bagsværd near Copenhagen, NNBF is a business unit within Novo Nordisk A/S, responsible for the company's venture capital activities. Investments are made on the books of Novo Nordisk A/S out of internal financial resources. NNBF is managed as an evergreen fund. | Finance |